distinguish between the entities. 4 Clinical characteristics might also be helpful in making the distinction, including no history of CML or myeloproliferative disorder, no evidence of chronic or accelerated phases of CML after induction therapy, and no
Search Results
Vijaya Raj Bhatt, Mojtaba Akhtari, R. Gregory Bociek, Jennifer N. Sanmann, Ji Yuan, Bhavana J. Dave, Warren G. Sanger, Anne Kessinger, and James O. Armitage
Jordan K. Schaefer, Amro Elshoury, Victoria R. Nachar, Michael B. Streiff, and Ming Y. Lim
General Anticoagulant Characteristics Anticoagulants recommended in current CAT treatment guidelines include low-molecular-weight heparin (LMWH), warfarin, and in recent years, the direct oral anticoagulants (DOACs). 4 Fondaparinux is also occasionally
Mohamedtaki A. Tejani, Anna ter Veer, Dana Milne, Rebecca Ottesen, Tanios Bekaii-Saab, Al B. Benson III, Deborah Schrag, Stephen Shibata, John Skibber, Martin Weiser, Neal Wilkinson, and Steven J. Cohen
. All data used in this study, including patient and treatment characteristics, were longitudinally abstracted from medical records by trained data managers at each of the 8 participating Member Institutions. Eligibility for the Outcomes Database for CRC
Christopher Nevala-Plagemann, Siddharth Iyengar, Andrew D. Trunk, Lisa Pappas, Benjamin Haaland, and Ignacio Garrido-Laguna
Guidelines; Version 2.2021) do not specify a preferred chemotherapy plus targeted therapy combination for the up-front management of fit patients with left-sided RAS/RAF WT mCRC. 10 Clearly there is a need to identify patient or tumor characteristics that
Christopher M. Booth, Sulaiman Nanji, Xuejiao Wei, Yingwei Peng, James J. Biagi, Timothy P. Hanna, Monika K. Krzyzanowska, and William J. Mackillop
16 weeks after surgery. Characteristics of the study population are shown in Table 1 . The median age was 70 years and 52% were male. Use of ACT ACT was delivered to 66% (1,861/2,801) of the study population. Use rates remained stable
Nikolai A. Podoltsev, Mengxin Zhu, Amer M. Zeidan, Rong Wang, Xiaoyi Wang, Amy J. Davidoff, Scott F. Huntington, Smith Giri, Steven D. Gore, and Xiaomei Ma
sociodemographic characteristics: age at diagnosis, sex, race, and Medicare Part D low-income subsidy, a marker for reduced out-of-pocket cost sharing and lower socioeconomic status. Receipt of influenza vaccination in the 12 months before ET diagnosis was included
Po-Ju Lin, Brian J. Altman, Nikesha J. Gilmore, Kah Poh Loh, Richard F. Dunne, Javier Bautista, Chunkit Fung, Michelle C. Janelsins, Luke J. Peppone, Marianne K. Melnik, Kim O. Gococo, Michael J. Messino, and Karen M. Mustian
demographic data and characteristics were examined with 2-tailed t tests for continuous variables and chi-square tests for categorical variables. Within-group differences in CRF’s interference with walking, PA, and QoL were assessed using 2-tailed t tests
Quisette P. Janssen, Jacob L. van Dam, Laura R. Prakash, Deesje Doppenberg, Christopher H. Crane, Casper H.J. van Eijck, Susannah G. Ellsworth, William R. Jarnagin, Eileen M. O’Reilly, Alessandro Paniccia, Marsha Reyngold, Marc G. Besselink, Matthew H.G. Katz, Ching-Wei D. Tzeng, Amer H. Zureikat, Bas Groot Koerkamp, Alice C. Wei, and for the Trans-Atlantic Pancreatic Surgery (TAPS) Consortium
with concurrent chemotherapy) or stereotactic body RT (SBRT) regimens of ≥5 Gy per fraction in 5 fractions. Data Collection and Definitions Prespecified data on patient demographics, tumor characteristics, treatment details, and clinical and
Wen-Zhuo He, Wan-Ming Hu, Fang Wang, Yu-Ming Rong, Lin Yang, Qian-Kun Xie, Yuan-Zhong Yang, Chang Jiang, Hui-Juan Qiu, Jia-Bin Lu, Bei Zhang, Pei-Rong Ding, Xiao-Jun Xia, Jian-Yong Shao, and Liang-Ping Xia
selection flowchart is summarized in supplemental eFigure 1 . Statistical Analysis All statistical analyses were performed using SPSS Statistics, version 13.0 (SPSS Inc). Frequencies and descriptive statistics were used to report patient characteristics and
Johannes Uhlig, Michael Cecchini, Amar Sheth, Stacey Stein, Jill Lacy, and Hyun S. Kim
KRAS wild-type). Table 1. Patient and Tumor Characteristics According to Microsatellite Status Table 2. Patient and Tumor Characteristics According to KRAS Status CRC Mutation Status: Impact on OS and Interaction With Tumor Location For survival